PG
Priyanka Gupta
Boehringer Ingelheim Corp USA, ReceptorLogicInc, Rensselaer Polytechnic Institute, Texas Tech University
0000-0001-6483-3069
Employment
-
Boehringer Ingelheim Corp USA Principal Scientist/Lab Head2010 - Present
-
ReceptorLogicInc Research Assistant2008 - 2010
Education
-
Rensselaer Polytechnic Institute Ph.D2015 - 2021
-
Texas Tech University M.S2007 - 2009
Projects & Funding
Projects & funding information is unavailable.
Publications (17)
- How can we discover developable antibody-based biotherapeutics? Save
- Human Dose and Pharmacokinetic Predictions for Biologics at Boehringer Ingelheim: A Retrospective Analysis. Save
- Sema3A Antibody BI-X Prevents Cell Permeability and Cytoskeletal Collapse in HRMECs and Increases Tip Cell Density in Mouse Oxygen-Induced Retinopathy. Save
- Antibodies with Weakly Basic Isoelectric Points Minimize Trade-offs between Formulation and Physiological Colloidal Properties Save
- Intrinsic physicochemical profile of marketed antibody-based biotherapeutics Save
- Discovery-stage identification of drug-like antibodies using emerging experimental and computational methods Save
- Physicochemical Rules for Identifying Monoclonal Antibodies with Drug-like Specificity Save
- Plasma Concentrations of Myeloid-Derived Growth Factor in Healthy Individuals and Patients with Acute Myocardial Infarction as Assessed by Multiple Reaction Monitoring-Mass Spectrometry Save
- Crystal structure and receptor-interacting residues of MYDGF — a protein mediating ischemic tissue repair Save
- GDF11 decreases pressure overload-induced hypertrophy, but can cause severe cachexia and premature death Save